BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29896858)

  • 1. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
    Madden K; Janitell C; Sower D; Yang S
    Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy.
    Boan P; Hewison C; Swaminathan R; Irish A; Warr K; Sinniah R; Pryce TM; Flexman J
    BMC Infect Dis; 2016 Jul; 16():342. PubMed ID: 27448566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
    Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
    Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
    Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
    J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.
    Babel N; Fendt J; Karaivanov S; Bold G; Arnold S; Sefrin A; Lieske E; Hoffzimmer M; Dziubianau M; Bethke N; Meisel C; Grütz G; Reinke P
    Transplantation; 2009 Jul; 88(1):89-95. PubMed ID: 19584686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK polyomavirus in the urine for follow-up of kidney transplant recipients.
    Brochot E; Descamps V; Handala L; Faucher J; Choukroun G; Helle F; Castelain S; François C; Duverlie G; Touzé A
    Clin Microbiol Infect; 2019 Jan; 25(1):112.e1-112.e5. PubMed ID: 30076973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients.
    Tan SK; Huang C; Sahoo MK; Weber J; Kurzer J; Stedman MR; Concepcion W; Gallo AE; Alonso D; Srinivas T; Storch GA; Subramanian AK; Tan JC; Pinsky BA
    J Infect Dis; 2019 Jul; 220(3):370-376. PubMed ID: 30869132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients.
    Leung AY; Chan M; Tang SC; Liang R; Kwong YL
    J Virol Methods; 2002 May; 103(1):51-6. PubMed ID: 11906732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.